Michael Sitzman joined McDermott Will & Emery as a partner in its intellectual property practice group in San Francisco, the firm announced Tuesday.

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms ...

Techniques such as Polymerase Chain Reaction (PCR), CRISPR-Cas9 gene editing, and recombinant DNA technology have ...

New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Aspiring participants of the GATE 2025 Biotechnology (BT) exam must go through the syllabus of Biotechnology (BT). The ...

Drawing parallels with the rise of the biotech industry, MIT faculty propose strategic initiatives and a practical roadmap to ...

Discover the history of insulin, from its discovery to modern production methods, and the ongoing quest for a cure.

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

2024] With publication of the in-depth scientific description of recombinant DNA technology by Stanley Cohen and Herbert Boyer in an article in PNAS in November 1973, the blueprint for genetic ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

Good afternoon, ladies and gentlemen, and welcome everyone to the Maravai Life Sciences third-quarter 2024 earnings conference call. (Operator Instructions) I would now like to turn the call over to ...